News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
215 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (201)
2 (268)
3 (272)
4 (305)
5 (108)
6 (6)
7 (10)
8 (235)
9 (334)
10 (239)
11 (333)
12 (116)
13 (2)
14 (3)
15 (255)
16 (204)
17 (173)
18 (167)
19 (88)
20 (9)
21 (8)
22 (183)
23 (215)
24 (191)
25 (218)
26 (104)
28 (2)
29 (12)
30 (225)
31 (296)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
28
29
30
31
Pharm Country
Avantor® Releases 2023 Science for Goodness Sustainability Report
Avantor, Inc. released its 2023 Sustainability Report, highlighting progress made in 2022 implementing environment, social & governance practices, in alignment with the company’s mission to set science in motion to create a better world.
May 23, 2023
·
3 min read
BioCapital
Incyte to Present at Upcoming Investor Conferences - May 23, 2023
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June.
May 23, 2023
·
1 min read
FDA
Vega Therapeutics Receives FDA Orphan Drug Designation for VGA039 for the Treatment of von Willebrand Disease
Vega Therapeutics , Inc., a clinical stage biotechnology company developing novel therapies for rare blood disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for VGA039 for the treatment of the rare bleeding disorder, von Willebrand disease (VWD).
May 23, 2023
·
2 min read
Genetown
Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences - May 23, 2023
Deciphera Pharmaceuticals, Inc. today announced that members of the management team will participate in fireside chats at the following investor conferences.
May 23, 2023
·
1 min read
Business
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2023 Financial Results
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2023 financial results on Thursday, May 25, 2023, before markets open.
May 23, 2023
·
3 min read
Biotech Beach
QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
QuidelOrtho Corporation announced today that members of its management team are scheduled to participate in the William Blair 43rd Annual Growth Stock Conference in Chicago, Illinois, on June 6, 2023.
May 23, 2023
·
1 min read
Business
Verge Genomics to Incorporate Emerald Digital Health Technology into its ALS Phase 1b Proof-of-Concept Clinical Trial
Verge Genomics announced that Emerald Innovations’ wireless digital health technology will be used to capture critical patient data in its planned Phase 1b proof-of-concept study of the PIKfyve inhibitor VRG50635, a novel therapeutic in clinical development for amyotrophic lateral sclerosis (ALS).
May 23, 2023
·
4 min read
Genetown
iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on June 1, 2023
iSpecimen Inc. today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group LLC (“Maxim”) and M-Vest, a division of Maxim, on Thursday, June 1, 2023.
May 23, 2023
·
1 min read
Business
Aurora Spine Corporation Schedules Release of First Quarter Fiscal Year 2023 Financial Results and Conference Call
Aurora Spine Corporation today announced it will issue its financial results press release for the first quarter fiscal 2023 ended March 31, 2023, on Wednesday, May 24, 2023.
May 23, 2023
·
3 min read
Business
Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD
Aclarion, Inc. announced that Dean Karahalios, M.D., Medical Director of Brain & Spine Institute at Advocate Aurora Health Care in Illinois, will advise the company as a key opinion leader nationally.
May 23, 2023
·
4 min read
Previous
18 of 22
Next